Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

WEBINAR SERIES RECAP | Ending the Public Health Emergency + Post-Pandemic Check-Up

Client Alert, Multimedia
May 10, 2023

Some may take the position that the rest of the country already returned to a new “normal” following the COVID-19 pandemic. But healthcare providers continue to implement COVID protocols and navigate the ever-changing healthcare regulations at both the federal and state levels. It is important for healthcare providers to take time for a “Healthcare Check-Up” with the start of 2023 and the ending of the Public Health Emergency (“PHE”).

BMD Healthcare and Employment + Labor Attorneys presented this 6-part series on the ending of the PHE.

Telehealth Updates

Originally Aired April 5, 2023

Telehealth became an extremely popular method of providing service during the PHE. However, with the PHE ending, do you know whether your telehealth practice will be ending with it? Learn about the many changes that are on the horizon for telehealth including the elimination of audio-only services for some payors, documentation requirements, medical necessity and consent requirements, ongoing OIG audits, and tele-behavioral health in this webinar hosted by BMD Partner Ashley B. Watson. 



Medicaid Updates

Originally Aired April 12, 2023

There will no longer be any expansion of Medicaid so many may lose their coverage. This makes the No Surprises Act very important because many will be paying cash (and will not be covered). Find out how this will impact you in this webinar hosted by BMD Member Daphne L. Kackloudis.



Licensure Requirements

Originally Aired April 19, 2023

Waivers of licensure requirements to address the PHE are (if not already based on the state) coming to an end, including those creating telehealth or moonlighting flexibilities. Some states have already taken action to adopt permanent revised licensure laws, including adoption of multi-state licensing compacts.  Others have reverted back to full licensure requirements.  Find out about how the closure of the PHE affects professional licensure requirements in this webinar hosted by BMD Member Jeana M. Singleton.



Payment for COVID Testing / Treatment

Originally Aired April 26, 2023

Payment for COVID testing, vaccines, and treatment is changing. Insurance companies will no longer be required to pay 100% as they are under the FFCRA. Government will no longer pay for the vaccines or testing. Patients will be required to pay out of pocket for the treatments and testing. Vaccines will be subject to copayment and deductible requirements. You will also learn about FDA and emergency use for vaccines. This webinar is hosted by BMD Vice President Amanda L. Waesch.



Employers + COVID

Originally Aired May 3, 2023

Learn about updated employer requirements for the vaccine mandate and time off for COVID. Learn details of the CDC guidance and policies and what states are requiring. Find out what documents you should review to make sure they are up-to-date with the ending of the PHE. This webinar is hosted by BMD Partner and Co-Chair of the Employment and Labor Law Group Bryan Meek.



PHE Recap

Originally Aired May 10, 2023

This webinar highlights the key points from each webinar on telehealth, Medicaid, Licensure Requirements, Payment for COVID testing/treatment, and Employers & COVID. This webinar is hosted by BMD Attorneys Ashley B. Watson, Daphne L. Kackloudis, Jeana M. Singleton, Amanda L. Waesch and Bryan Meek.

PHEAmanda L. WaeschAshley WatsonDaphne KackloudisJeana SingletonBryan Meek
Client Alert

Name, Image, and Likeness Agreements in Healthcare

November 14, 2025For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.Client Alert

Compounding GLP-1 Drugs - Recent Updates

November 13, 2025Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.Client Alert

Top Compliance Risks for Ohio Med-Spas in 2025

November 11, 2025The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.Client Alert

Pre and Postnuptial Agreements | Necessary, Maybe, What Happened to Forever?

November 7, 2025Both Florida and Ohio now allow clients to enter into a prenuptial or postnuptial agreement prior to marriage or after marriage (Ohio previously did not allow postnuptial agreements). Both documents have statutory guidelines that must be followed in terms of execution and financial disclosure.Client Alert

DHS Ends All Employment Authorization Auto-Extensions

October 29, 2025Effective October 30, 2025, DHS ends all automatic work authorization renewals. The 540-day extension applies only to renewals filed before this date, and there is no grace period for expired EADs filed on or after October 30. Employers must audit EADs, train staff, ensure I-9 compliance, and plan for work authorization gaps. Penalties for noncompliance can be severe.
Older posts